Leerink Partnrs Cuts Earnings Estimates for Tenet Healthcare

Tenet Healthcare Co. (NYSE:THC) – Investment analysts at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for shares of Tenet Healthcare in a note issued to investors on Wednesday, February 12th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $3.07 per share for the quarter, down from their prior forecast of $3.57. The consensus estimate for Tenet Healthcare’s current full-year earnings is $11.37 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q1 2025 earnings at $3.07 EPS, Q3 2025 earnings at $2.71 EPS, Q3 2025 earnings at $2.71 EPS, FY2025 earnings at $11.82 EPS, FY2025 earnings at $11.82 EPS, FY2026 earnings at $13.64 EPS, FY2026 earnings at $13.64 EPS, FY2027 earnings at $15.90 EPS and FY2027 earnings at $15.90 EPS.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.95 by $0.49. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%.

A number of other equities analysts have also issued reports on the company. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $177.00 price target on shares of Tenet Healthcare in a research note on Thursday. The Goldman Sachs Group lowered Tenet Healthcare from a “buy” rating to a “neutral” rating and decreased their price target for the company from $196.00 to $140.00 in a research note on Monday, December 16th. UBS Group increased their price target on Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Truist Financial cut their price objective on Tenet Healthcare from $190.00 to $175.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, KeyCorp cut their price objective on Tenet Healthcare from $200.00 to $185.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Four research analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $163.19.

Tenet Healthcare Stock Performance

Shares of NYSE THC opened at $133.40 on Monday. The stock has a fifty day moving average price of $133.32 and a two-hundred day moving average price of $148.10. The company has a debt-to-equity ratio of 2.35, a quick ratio of 1.52 and a current ratio of 1.58. The firm has a market cap of $12.69 billion, a P/E ratio of 4.27, a PEG ratio of 0.63 and a beta of 2.05. Tenet Healthcare has a 1 year low of $88.57 and a 1 year high of $171.20.

Institutional Investors Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently made changes to their positions in the business. FMR LLC lifted its stake in shares of Tenet Healthcare by 88.0% in the third quarter. FMR LLC now owns 7,700,693 shares of the company’s stock valued at $1,279,855,000 after buying an additional 3,604,161 shares during the period. Geode Capital Management LLC lifted its stake in shares of Tenet Healthcare by 3.5% in the fourth quarter. Geode Capital Management LLC now owns 2,116,121 shares of the company’s stock valued at $268,591,000 after buying an additional 71,454 shares during the period. Norges Bank bought a new stake in shares of Tenet Healthcare in the fourth quarter valued at about $190,819,000. Dimensional Fund Advisors LP lifted its stake in shares of Tenet Healthcare by 22.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,493,532 shares of the company’s stock valued at $188,524,000 after buying an additional 272,906 shares during the period. Finally, AQR Capital Management LLC lifted its stake in shares of Tenet Healthcare by 20.8% in the fourth quarter. AQR Capital Management LLC now owns 872,117 shares of the company’s stock valued at $110,087,000 after buying an additional 150,361 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.